Federated Hermes’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Federated Hermes’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-424	Closed	-$5K	–	2284
2017 Q3	$5K	Hold	424	–	–	﹤0.01%	1976
2017 Q2	$4K	Hold	424	–	–	﹤0.01%	2001
2017 Q1	$5K	Hold	424	–	–	﹤0.01%	1955
2016 Q4	$6K	Hold	424	–	–	﹤0.01%	1926
2016 Q3	$5K	Sell	424 -725	-63%	-$8.54K	﹤0.01%	1932
2016 Q2	$13K	Sell	1,149 -2,779	-71%	-$31.1K	﹤0.01%	1786
2016 Q1	$43K	Sell	3,928 -46,293	-92%	-$585K	﹤0.01%	1685
2015 Q4	$868K	Buy	50,221 +3,700	+8%	+$66.3K	﹤0.01%	1149
2015 Q3	$924K	Buy	46,521 +2,848	+7%	+$65.3K	﹤0.01%	1114
2015 Q2	$718K	Buy	43,673 +30,960	+244%	+$537K	﹤0.01%	1244
2015 Q1	$198K	Buy	12,713 +11,733	+1,197%	+$182K	﹤0.01%	1512
2014 Q4	$14K	Buy	+980	New	+$10.3K	﹤0.01%	1725

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Federated Hermes's SCMP Position: Q4 2017 in Review

Federated Hermes sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 424 shares — an estimated $5K sold.

Federated Hermes first reported a position in SCMP in Q4 2014 and held it in 12 quarters. The position peaked at $924K in Q3 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Federated Hermes reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Federated Hermes sold 424 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $5K.
Federated Hermes first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 12 quarters.
Federated Hermes's Sucampo Pharmaceuticals, Inc. position peaked at $924K in Q3 2015.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.